ES450582A1 - Un procedimiento de preparacion de 1-4-dihidropiridinas. - Google Patents

Un procedimiento de preparacion de 1-4-dihidropiridinas.

Info

Publication number
ES450582A1
ES450582A1 ES450582A ES450582A ES450582A1 ES 450582 A1 ES450582 A1 ES 450582A1 ES 450582 A ES450582 A ES 450582A ES 450582 A ES450582 A ES 450582A ES 450582 A1 ES450582 A1 ES 450582A1
Authority
ES
Spain
Prior art keywords
substituted
methylthiopyrid
compounds
dicarbalkoxy
dihydropyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES450582A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexachimie SA
Original Assignee
Hexachimie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB33501/75A external-priority patent/GB1511694A/en
Application filed by Hexachimie SA filed Critical Hexachimie SA
Publication of ES450582A1 publication Critical patent/ES450582A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES450582A 1975-08-12 1976-08-09 Un procedimiento de preparacion de 1-4-dihidropiridinas. Expired ES450582A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB33501/75A GB1511694A (en) 1975-08-12 1975-08-12 Pyridine derivatives
GB4518875 1975-10-31

Publications (1)

Publication Number Publication Date
ES450582A1 true ES450582A1 (es) 1977-11-16

Family

ID=26261898

Family Applications (1)

Application Number Title Priority Date Filing Date
ES450582A Expired ES450582A1 (es) 1975-08-12 1976-08-09 Un procedimiento de preparacion de 1-4-dihidropiridinas.

Country Status (19)

Country Link
US (1) US4096270A (US20040025266A1-20040212-C00001.png)
JP (1) JPS5223081A (US20040025266A1-20040212-C00001.png)
AR (1) AR209672A1 (US20040025266A1-20040212-C00001.png)
AT (1) AT351025B (US20040025266A1-20040212-C00001.png)
AU (1) AU504839B2 (US20040025266A1-20040212-C00001.png)
CA (1) CA1079284A (US20040025266A1-20040212-C00001.png)
CH (1) CH612678A5 (US20040025266A1-20040212-C00001.png)
CS (1) CS194774B2 (US20040025266A1-20040212-C00001.png)
DD (1) DD126696A5 (US20040025266A1-20040212-C00001.png)
DE (1) DE2635916A1 (US20040025266A1-20040212-C00001.png)
DK (1) DK362676A (US20040025266A1-20040212-C00001.png)
ES (1) ES450582A1 (US20040025266A1-20040212-C00001.png)
FR (1) FR2320750A1 (US20040025266A1-20040212-C00001.png)
MX (1) MX3464E (US20040025266A1-20040212-C00001.png)
NL (1) NL7608989A (US20040025266A1-20040212-C00001.png)
NO (1) NO144457C (US20040025266A1-20040212-C00001.png)
PT (1) PT65456B (US20040025266A1-20040212-C00001.png)
SE (1) SE7608959L (US20040025266A1-20040212-C00001.png)
SU (1) SU1007556A3 (US20040025266A1-20040212-C00001.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines
DE4236707A1 (de) * 1992-10-30 1994-05-05 Bayer Ag 4-Heterocyclyl substituierte Dihydropyridine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1813436C3 (de) * 1968-12-07 1979-01-11 Bayer Ag, 5090 Leverkusen N-Substituierte 2,6-Dimethyl-l,4dihydropyridine
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
ZA7152B (en) * 1970-01-24 1971-10-27 Bayer Ag New pharmaceutically active 1,4-dihydropyridines
DE2005116C3 (de) * 1970-02-05 1980-02-14 Bayer Ag, 5090 Leverkusen Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2218644C3 (de) * 1972-04-18 1982-08-19 Bayer Ag, 5090 Leverkusen Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2248150A1 (de) * 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
SU1007556A3 (ru) 1983-03-23
AU1656976A (en) 1978-02-09
JPS5422986B2 (US20040025266A1-20040212-C00001.png) 1979-08-10
FR2320750B1 (US20040025266A1-20040212-C00001.png) 1979-09-28
PT65456A (fr) 1976-09-01
CS194774B2 (en) 1979-12-31
AU504839B2 (en) 1979-11-01
CA1079284A (en) 1980-06-10
PT65456B (fr) 1978-02-10
AT351025B (de) 1979-07-10
SE7608959L (sv) 1977-02-13
DK362676A (da) 1977-02-13
MX3464E (es) 1980-12-09
AR209672A1 (es) 1977-05-13
NO144457B (no) 1981-05-25
ATA568776A (de) 1978-12-15
DE2635916A1 (de) 1977-02-24
JPS5223081A (en) 1977-02-21
CH612678A5 (US20040025266A1-20040212-C00001.png) 1979-08-15
NO144457C (no) 1981-09-02
FR2320750A1 (fr) 1977-03-11
NO762790L (US20040025266A1-20040212-C00001.png) 1977-02-15
DD126696A5 (US20040025266A1-20040212-C00001.png) 1977-08-03
US4096270A (en) 1978-06-20
NL7608989A (nl) 1977-02-15

Similar Documents

Publication Publication Date Title
ES440619A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas.
DE3782883D1 (de) Pyridincarboxamid-derivate und ihre verwendung als fungizides mittel.
UA41244C2 (uk) Похідні пропенової кислоти, що мають фунгіцидну активність
IL57030A (en) Cerebral therapeutic compositions containing 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl)-pyridine 3,5-dicarboxylic acid 3-(beta-methoxyethyl ester)-5-(isopropyl ester)
GB1346724A (en) 1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and esters and their preparation
GB1477114A (en) 1,4-dihydropyridinecarboxylic acid aralkyl esters processes for their preparation and their use as medicaments
ES450582A1 (es) Un procedimiento de preparacion de 1-4-dihidropiridinas.
ES8301469A1 (es) Procedimiento para preparar derivados de 2(1h)-piridona
NL990014I1 (nl) Methyl, isopropyl-4-(2,1,3-benzoxadiazool-4-yl)-2,6-dimethyl-1,4-dihydro pyridine-3,5-dicarboxylaat en farmaceutisch preparaat dat deze verbinding bevat.
DK355784D0 (da) 2-(heterocyclylalkoxymethyl)-4-(aryl eller heteroaryl)-6-methyl-1,4-dihydropyridin-3,5- dicarboxylsyreestere og deres anvendelse til behandling af cardiovasculaere lidelser samt farmaceutiske praeparater indeholdende disse forbindelser
ES412322A1 (es) Procedimiento para la obtencion de derivados de 2-amino-1,4-dihidropiridina.
EP0300882A3 (en) Novel 5-aminomethylene-2,4-imidazolidinediones and 5-aminomethylene-2-thionoimidazolidine-4-ones
EP0361489A3 (en) Novel 3,4-diaminoquinoline and pyridine compounds
MY101142A (en) 1, 4-dihydropyridine derivative, process for production thereof, and pharmaceutical use thereof.
ATE37183T1 (de) Chinazolin- und isochinolin-derivate.
DK539980A (da) Fremgangsmaade til fremstilling af 2-metyl-6-substituerede-4-i (2,3-diklorfenyl-1,4-dihydropyridin)-3,5-dikarboxylsyre-3,5-destere
DK156718C (da) Analogifremgangsmaade til fremstilling af substituerede 2-phenyl-2-(pyridyloxy, pyridylamino eller pyridylthio)-ethylaminer eller syreadditionssalte deraf
ATE67757T1 (de) Pyrimidinverbindungen.
ES462034A1 (es) Procedimiento para la obtencion de amino-dihidro-piridinas.
AU507892B2 (en) 1, 4-Dihydro-2, 6-dimethyl-4-(3-nitrophenyl)-3, 5 pyridine dicarboxylic acid isopropyl, 2-propoxyethy1 esters
DK157854C (da) Analogifremgangsmaade til fremstilling af alfa-aryl-alfa-(2-pyridyl)-alkansyrederivater
ES8500057A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina.
KR870002135A (ko) 광학적 활성, 치환된 1,4-디히드로피리딘의 제조방법
ES8300707A1 (es) Procedimiento para preparar derivados del acido nicotinico.
SE8303617D0 (sv) 2,6-dimetyl-4-(2,3-diklorfenyl)-1,4-dihydropyridin-3,5-dikarboxylsyra-3-metylester-5-etylester